KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to $2.9 billion.

  • AbbVie's Dividends Paid - Common rose 581.61% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 billion, marking a year-over-year increase of 549.59%. This contributed to the annual value of $11.0 billion for FY2024, which is 461.14% up from last year.
  • Per AbbVie's latest filing, its Dividends Paid - Common stood at $2.9 billion for Q3 2025, which was up 581.61% from $2.9 billion recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Dividends Paid - Common peaked at $2.9 billion during Q1 2025, and registered a low of $2.3 billion during Q2 2021.
  • Its 5-year average for Dividends Paid - Common is $2.6 billion, with a median of $2.6 billion in 2023.
  • Per our database at Business Quant, AbbVie's Dividends Paid - Common soared by 3184.93% in 2021 and then soared by 417.14% in 2024.
  • Quarter analysis of 5 years shows AbbVie's Dividends Paid - Common stood at $2.3 billion in 2021, then grew by 8.3% to $2.5 billion in 2022, then increased by 4.79% to $2.6 billion in 2023, then increased by 4.8% to $2.8 billion in 2024, then increased by 5.78% to $2.9 billion in 2025.
  • Its Dividends Paid - Common was $2.9 billion in Q3 2025, compared to $2.9 billion in Q2 2025 and $2.9 billion in Q1 2025.